This unit presents three models used in the Pediatric Preclinical Testing Program of the National Cancer Institute (NCI) for preclinical testing of new chemical entities (NCEs), along with appropriate methods for data analysis. The first is the classical subcutaneous xenograft model used for many solid tumors, the second is the disseminated human leukemia model established by Lock and colleagues, and the third is a disseminated model of neuroblastoma that recapitulates many of the characteristics of advanced clinical disease.
|Original language||English (US)|
|Journal||Current protocols in pharmacology / editorial board, S.J. Enna (editor-in-chief) ... [et al.]|
|State||Published - Dec 2007|
ASJC Scopus subject areas